Latest News

A Global Gamechanger: Sheba and the NIH Join Forces to Develop a Revolutionary Pan-Coronavirus Vaccine

A Global Gamechanger: Sheba and the NIH Join Forces to Develop a Revolutionary Pan-Coronavirus Vaccine

Sheba Pandemic Research Institute (SPRI) has joined a groundbreaking collaboration with the National Institutes of Health (NIH)’s Vaccine Research Center, the Walter Reed Army Institute of Research, and pharmaceutical giant Sanofi. Researchers aim to develop booster vaccines that can provide comprehensive protection against multiple coronavirus variants, including SARS-CoV-2, revolutionizing virus care worldwide. Sheba’s COVID-19 research program, which involves over 9,000 healthcare workers, will serve as the framework for the design of the pan-coronavirus vaccine.

read more